Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Systemic immune-inflammation index (SII), based on peripheral lymphocyte, neutrophil, and platelet counts, was recently investigated as a prognostic marker in several tumors. However, SII has not been reported in esophageal squamous cell carcinoma (ESCC). We evaluated the prognostic value of the SII in 916 patients with ESCC who underwent radical surgery. Univariate and multivariate analyses were calculated by the Cox proportional hazards regression model. The time-dependent receiver operating characteristics (ROC) curve was used to compare the discrimination ability for OS. PSM (propensity score matching) was carried out to imbalance the baseline characteristics. Our results showed that SII, PLR, NLR and MLR were all associated with OS in ESCC patients in the Kaplan-Meier survival analysis. However, only SII was an independent risk factor for OS (HR = 1.24, 95% CI 1.01–1.53, P = 0.042) among these systemic inflammation scores. The AUC for SII was bigger than PLR, NLR and MLR. In the PSM analysis, SII still remained an independent predictor for OS (HR = 1.30, CI 1.05–1.60, P = 0.018). SII is a novel, simple and inexpensive prognostic predictor for patients with ESCC undergoing radical esophagectomy. The prognostic value of SII is superior to PLR, NLR and MLR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,434
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
Pennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390
Cancer-related inflammation and treatment effectiveness
Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70263-3 · Cited by 2,193
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Schumacher, D., Strilic, B., Sivaraj, K. K., Wettschureck, N., & Offermanns, S. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.008 · Cited by 630
Kusumanto, Y. H., Dam, W. A., Hospers, G. A. P., Meijer, C., & Mulder, N. H. (2003) · Angiogenesis · doi:10.1023/b:agen.0000029415.62384.ba · Cited by 530
Yodying, H., Matsuda, A., Miyashita, M., Matsumoto, S., Sakurazawa, N., Yamada, M., & Uchida, E. (2016) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4869-5 · Cited by 386
Hong, X., Cui, B., Wang, M., Yang, Z., Wang, L., & Xu, Q. (2015) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.236.297 · Cited by 326
Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?
Müller, I., Munder, M., Kropf, P., & Hänsch, G. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.007 · Cited by 277
Dual Roles for Immunity in Gastrointestinal Cancers
Ferrone, C., & Dranoff, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.27.9992 · Cited by 241
Passardi, A., Scarpi, E., Cavanna, L., Dall’Agata, M., Tassinari, D., Leo, S., Bernardini, I., Gelsomino, F., Tamberi, S., Brandes, A. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8901 · Cited by 156
Huang, L., Liu, S., Lei, Y., Wang, K., Xu, M., Chen, Y., Liu, B., Chen, Y., Fu, Q., Zhang, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9923 · Cited by 77
Bains, S. J., Mahic, M., Myklebust, T. Å., Småstuen, M. C., Yaqub, S., Dørum, L. M., Bjørnbeth, B. A., Møller, B., Brudvik, K. W., & Taskén, K. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.3519 · Cited by 75
Yang, Z., Zhang, J., Lu, Y., Xu, Q., Tang, B., Wang, Q., Zhang, W., Chen, S., Lu, L., & Chen, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5719 · Cited by 74
Liu, J.-S., Huang, Y., Yang, X., & Feng, J. (2015) · Europe PMC (PubMed Central) · Cited by 52
Shao, Y., Ning, Z., Chen, J., Geng, Y., Gu, W., Huang, J., Pei, H., Shen, Y., & Jiang, J. (2015) · Scientific Reports · doi:10.1038/srep18811 · Cited by 50
Self-citationNing, Z., Wang, Z., Chen, J., Li, X., Chen, L., Xu, B., Gu, W., Shao, Y., Xu, Y., Huang, J., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000580 · Cited by 28
Self-citationvan Staalduinen, J., Frouws, M. A., Reimers, M. S., Bastiaannet, E., van Herk‐Sukel, M. P. P., Lemmens, V. E. P. P., de Steur, W. O., Hartgrink, H. H., van de Velde, C. J. �., & Liefers, G. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.65 · Cited by 28
Cools‐Lartigue, J., Spicer, J. D., McDonald, B., Chow, S., Kubes, P., & Ferri, L. E. (2012) · Cancer Research · doi:10.1158/1538-7445.am2012-2972 · Cited by 27
He, Y., Xu, X., Li, S., Shan, S., Liang, D., & Baoen, S. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.09.003 · Cited by 26
Cited by
Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis
Yang, R., Chang, Q., Meng, X., Gao, N., & Wang, W. (2018) · Journal of Cancer · doi:10.7150/jca.25691 · Cited by 441
“Geng[8] 2016 China Asian ESCC 916 and 759 307 OS 8 M”
Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer
Huang, H., Liu, Q., Zhu, L., Zhang, Y., Lu, X., Wu, Y., & Liu, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39150-0 · Cited by 408
Guo, W., Song, Y., Sun, Y., Du, H., Cai, Y., You, Q., Fu, H., & Shao, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1071465 · Cited by 335
Zhong, J.-H., Huang, D.-H., & Chen, Z.-Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18856 · Cited by 307
Mahemuti, N., Jing, X., Zhang, N., Liu, C., Li, C., Cui, Z., Liu, Y., & Chen, J. (2023) · Nutrients · doi:10.3390/nu15051177 · Cited by 260
“Cervical cancer [13], esophageal cancer [14], and hepatocellular carcinoma [15] are examples.”
Background
Metadata
- Authors
- Geng, Y., Shao, Y., Zhu, D., Zheng, X., Zhou, Q., Zhou, W., Ni, X., Wu, C., & Jiang, J.
- Affiliations
- Soochow University (CN)
- Corresponding author
- Wu, Changping
- Jiang, Jingting
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-12-21
- Volume
- 6
- Issue
- 1
- Pages
- 39482-39482
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5175190
- OpenAlex
- W2563208071
- Cited by
- 233
- References
- 29
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 24 · 2021: 41 · 2020: 23 · 2019: 23 · 2018: 16 · 2017: 7
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31570877, 81301960)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- systemic immune-inflammation index, esophageal squamous cell carcinoma, prognostic factors, overall survival, radical esophagectomy, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, systemic inflammation, lymphocyte count, platelet count, neutrophil count
- MeSH terms
- Esophageal Squamous Cell Carcinoma, Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell, Esophageal Neoplasms, Female, Humans, Immunity, Inflammation, Male, Middle Aged, Prognosis, Regression Analysis, Retrospective Studies, Risk Factors, ROC Curve, Multivariate Analysis, Proportional Hazards Models, Esophagectomy, Kaplan-Meier Estimate, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.